NCT01809015View on ClinicalTrials.gov

Evaluation of Oral Anticoagulation With Vitamin K Antagonists - The thrombEVAL Study Programme

CompletedOBSERVATIONAL
Enrollment

2,318

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Anticoagulant Antagonists, Vitamin K and Other Coagulants Causing Adverse Effects in Therapeutic UseAtrial FibrillationVenous Thromboembolism
Trial Locations (1)

55131

University Medical Center of the Johannes Gutenberg University Mainz, Mainz

Sponsors
All Listed Sponsors
collaborator

Ministry of Health, Rhineland-Palatinate, Germany

UNKNOWN

collaborator

Ministry of Economics, Rhineland-Palatinate, Germany

UNKNOWN

collaborator

German Federal Ministry of Education and Research

OTHER_GOV

collaborator

Boehringer Ingelheim

INDUSTRY

collaborator

Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

INDUSTRY

collaborator

Sanofi

INDUSTRY

collaborator

IMO Institut GmbH

UNKNOWN

collaborator

PortaVita BV

UNKNOWN

collaborator

The German Heart Foundation

OTHER

collaborator

Bayer

INDUSTRY

lead

Johannes Gutenberg University Mainz

OTHER